Radiation and chemotherapy sensitizers and protectors

C. Norman Coleman, Andrew T. Turrisi

Research output: Contribution to journalArticle

Abstract

Radiosensitizers and radioprotectors are part of the chemical modifier approach to cancer therapy whereby the state of the tumor cells and/or normal tissues are modified such that a therapeutic gain is achieved using conventional radiation or chemotherapy. Radiosensitization can be achieved by the use of oxygen-mimetic compounds, agents that alter DNA sensitivity to irradiation, maneuvers that alter DNA repair processes, and manipulation of tissue oxygenation. Standard chemotherapeutic agents such as cisplatin can be utilized in a manner that optimizes the radiosensitization properties. Protection and sensitization can occur by altering the thiol status of the cell. The chemical modifiers field is both developing novel approaches to cancer treatment and increasing the understanding of basic cancer biology.

Original languageEnglish (US)
Pages (from-to)225-252
Number of pages28
JournalCritical Reviews in Oncology/Hematology
Volume10
Issue number3
DOIs
StatePublished - 1990
Externally publishedYes

Fingerprint

Radiation-Sensitizing Agents
Drug Therapy
Neoplasms
Oxygen Compounds
Sulfhydryl Compounds
DNA Repair
Cisplatin
Therapeutics
Radiation
DNA

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Radiation and chemotherapy sensitizers and protectors. / Coleman, C. Norman; Turrisi, Andrew T.

In: Critical Reviews in Oncology/Hematology, Vol. 10, No. 3, 1990, p. 225-252.

Research output: Contribution to journalArticle

Coleman, C. Norman ; Turrisi, Andrew T. / Radiation and chemotherapy sensitizers and protectors. In: Critical Reviews in Oncology/Hematology. 1990 ; Vol. 10, No. 3. pp. 225-252.
@article{64c9391ac4b34372a1d29780ed00c567,
title = "Radiation and chemotherapy sensitizers and protectors",
abstract = "Radiosensitizers and radioprotectors are part of the chemical modifier approach to cancer therapy whereby the state of the tumor cells and/or normal tissues are modified such that a therapeutic gain is achieved using conventional radiation or chemotherapy. Radiosensitization can be achieved by the use of oxygen-mimetic compounds, agents that alter DNA sensitivity to irradiation, maneuvers that alter DNA repair processes, and manipulation of tissue oxygenation. Standard chemotherapeutic agents such as cisplatin can be utilized in a manner that optimizes the radiosensitization properties. Protection and sensitization can occur by altering the thiol status of the cell. The chemical modifiers field is both developing novel approaches to cancer treatment and increasing the understanding of basic cancer biology.",
author = "Coleman, {C. Norman} and Turrisi, {Andrew T.}",
year = "1990",
doi = "10.1016/1040-8428(90)90033-O",
language = "English (US)",
volume = "10",
pages = "225--252",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Radiation and chemotherapy sensitizers and protectors

AU - Coleman, C. Norman

AU - Turrisi, Andrew T.

PY - 1990

Y1 - 1990

N2 - Radiosensitizers and radioprotectors are part of the chemical modifier approach to cancer therapy whereby the state of the tumor cells and/or normal tissues are modified such that a therapeutic gain is achieved using conventional radiation or chemotherapy. Radiosensitization can be achieved by the use of oxygen-mimetic compounds, agents that alter DNA sensitivity to irradiation, maneuvers that alter DNA repair processes, and manipulation of tissue oxygenation. Standard chemotherapeutic agents such as cisplatin can be utilized in a manner that optimizes the radiosensitization properties. Protection and sensitization can occur by altering the thiol status of the cell. The chemical modifiers field is both developing novel approaches to cancer treatment and increasing the understanding of basic cancer biology.

AB - Radiosensitizers and radioprotectors are part of the chemical modifier approach to cancer therapy whereby the state of the tumor cells and/or normal tissues are modified such that a therapeutic gain is achieved using conventional radiation or chemotherapy. Radiosensitization can be achieved by the use of oxygen-mimetic compounds, agents that alter DNA sensitivity to irradiation, maneuvers that alter DNA repair processes, and manipulation of tissue oxygenation. Standard chemotherapeutic agents such as cisplatin can be utilized in a manner that optimizes the radiosensitization properties. Protection and sensitization can occur by altering the thiol status of the cell. The chemical modifiers field is both developing novel approaches to cancer treatment and increasing the understanding of basic cancer biology.

UR - http://www.scopus.com/inward/record.url?scp=0025110301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025110301&partnerID=8YFLogxK

U2 - 10.1016/1040-8428(90)90033-O

DO - 10.1016/1040-8428(90)90033-O

M3 - Article

C2 - 2257086

AN - SCOPUS:0025110301

VL - 10

SP - 225

EP - 252

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 3

ER -